NICE recommends two more cancer drugs for routine NHS use

The National Institute for Health and Care Excellence (NICE), the health technology assessment body, has issued positive opinions on two bowel cancer drugs, cetuximab and panitumumab, that were previously available through the cancer drugs fund (CDF). …